Results 301 to 310 of about 560,370 (324)
Some of the next articles are maybe not open access.
International Forum of Allergy & Rhinology, 2014
BackgroundAllergic rhinitis, asthma, and Hymenoptera sensitivity affect approximately 20%, 9%, and 0.66% to 3.3% of adults in the United States, respectively. Various environmental control measures and pharmacologic options are available for symptomatic treatment of allergic rhinitis and allergic asthma.
Ansley M. Roche, Sarah K. Wise
openaire +3 more sources
BackgroundAllergic rhinitis, asthma, and Hymenoptera sensitivity affect approximately 20%, 9%, and 0.66% to 3.3% of adults in the United States, respectively. Various environmental control measures and pharmacologic options are available for symptomatic treatment of allergic rhinitis and allergic asthma.
Ansley M. Roche, Sarah K. Wise
openaire +3 more sources
Immunotherapy in cholangiocarcinoma
Current Opinion in Gastroenterology, 2021Purpose of review Cholangiocarcinoma is an aggressive heterogeneous group of cancers of the biliary epithelium and most patients are detected with advanced metastatic disease with poor prognosis. The therapeutic options are limited, and the current standard care as systemic therapy is still cytotoxic chemotherapy.
Weijing Sun, Raed Al-Rajabi
openaire +2 more sources
Veterinary Clinics of North America: Small Animal Practice, 2009
The immune system is generally divided into 2 primary components: the innate immune response, and the highly specific but more slowly developing adaptive or acquired immune response. Immune responses can be further separated by whether they are induced by exposure to a foreign antigen (an "active" response) or whether they are transferred through serum
openaire +4 more sources
The immune system is generally divided into 2 primary components: the innate immune response, and the highly specific but more slowly developing adaptive or acquired immune response. Immune responses can be further separated by whether they are induced by exposure to a foreign antigen (an "active" response) or whether they are transferred through serum
openaire +4 more sources
2018
While melanoma is less common than some other skin cancers, it is responsible for nearly 10,000 deaths in the USA each year alone. For many decades, very limited treatment options were available for patients with metastatic melanoma. However, recent breakthroughs have brought new hopes for patients and providers.While targeted therapy with BRAF and MEK
Omar Alhalabi +2 more
openaire +4 more sources
While melanoma is less common than some other skin cancers, it is responsible for nearly 10,000 deaths in the USA each year alone. For many decades, very limited treatment options were available for patients with metastatic melanoma. However, recent breakthroughs have brought new hopes for patients and providers.While targeted therapy with BRAF and MEK
Omar Alhalabi +2 more
openaire +4 more sources
Hematology/Oncology Clinics of North America, 2009
About 20% of all primary melanomas will spread. The likelihood of metastatic behavior correlates with prognostic factors such as tumor thickness, mitotic index, presence of ulceration, lymphocyte infiltration, age, gender, and anatomic site. Immunotherapies are developed for melanoma patients in stage IV who have distant metastases and in stage II to ...
Dirk Schadendorf +1 more
openaire +4 more sources
About 20% of all primary melanomas will spread. The likelihood of metastatic behavior correlates with prognostic factors such as tumor thickness, mitotic index, presence of ulceration, lymphocyte infiltration, age, gender, and anatomic site. Immunotherapies are developed for melanoma patients in stage IV who have distant metastases and in stage II to ...
Dirk Schadendorf +1 more
openaire +4 more sources
Science, 2020
New agonists of an innate immune pathway induce antitumor immunity in ...
Thomas F. Gajewski, Emily F. Higgs
openaire +3 more sources
New agonists of an innate immune pathway induce antitumor immunity in ...
Thomas F. Gajewski, Emily F. Higgs
openaire +3 more sources
2013
Introduction Passive immunization Active immunization General problems of active immunization Additional stimulation of the immune system Modern approaches to ...
openaire +1 more source
Introduction Passive immunization Active immunization General problems of active immunization Additional stimulation of the immune system Modern approaches to ...
openaire +1 more source
JAMA: The Journal of the American Medical Association, 1987
ALLERGEN immunotherapy is the process by which increasing doses of allergen are injected subcutaneously over time as a treatment to prevent allergic symptoms that usually occur on exposure to allergen. The effects of this therapy on the immunologic processes ascribed to allergic responses have been studied in great detail.
openaire +3 more sources
ALLERGEN immunotherapy is the process by which increasing doses of allergen are injected subcutaneously over time as a treatment to prevent allergic symptoms that usually occur on exposure to allergen. The effects of this therapy on the immunologic processes ascribed to allergic responses have been studied in great detail.
openaire +3 more sources
Surgical Oncology Clinics of North America, 2001
This article provides a basic overview of tumor immunology vaccines, current vaccine trials, and future directions of vaccine strategies for the treatment of metastatic cancers. As dendritic cells are the most potent antigen-presenting cell and central to the regulation, maturation, and maintenance of a cellular immune response to cancer, these cells ...
Ramsey M. Dallal, Michael T. Lotze
openaire +3 more sources
This article provides a basic overview of tumor immunology vaccines, current vaccine trials, and future directions of vaccine strategies for the treatment of metastatic cancers. As dendritic cells are the most potent antigen-presenting cell and central to the regulation, maturation, and maintenance of a cellular immune response to cancer, these cells ...
Ramsey M. Dallal, Michael T. Lotze
openaire +3 more sources
Emerging evidence for adapting radiotherapy to immunotherapy
Nature Reviews Clinical Oncology, 2023L. Galluzzi +3 more
semanticscholar +1 more source